Gentian Diagnostics News Today

The Global Cystatin C Assay Market Size was valued at USD 270.6 Million in 2023 and the Worldwide Cystatin C Assay Market Size is Expected to reach USD...

Q1 First quarter 2024 results Efficient diagnostics for better treatment decisions www.gentian.com ...

Q1 24 Presentation 30 April 2024 Important notice ...

Gentian Diagnostics ASAs general meeting has resolved to elect Ms. Hilja Ibert as chairperson of the board of directors. Ms. Ibert has therefore resigned as CEO effective April 29, 2024....

The board of directors appointed Mr. Njaal Kind as acting CEO of Gentian Diagnostics ASA. Mr. Kind joined Gentian in January 2018 as CFO. More recently he has been promoted to CFO/COO.During these...

Gentian Diagnostic AB is looking for a Sales and Application Specialist to join our Nordic sales team. You will be part of the Nordic Sales and Application team, based in Sweden or Norway, and...

Fact.MR’s latest study examines key trends prevalent across the particle-enhanced turbidimetric immunoassays market. It uncovers the factors driving the market in terms of application and end user. The report is intended at presenting an overview of drivers, restrains, and opportunities for prominent market players...

(2) ROCKVILLE, MD / ACCESSWIRE / May 3, 2021 / The American Kidney Fund (AKF) today announced a webinar, Cystatin C: Its utility as an alternative for creatinine-based eGFR, to educate healthcare practitioners about the cystatin C testing option for kidney health and help them effectively communicate about testing options to patients. The webinar, sponsored by Gentian Diagnostics, will take place tomorrow, Tuesday, May 4, 2021 from 1 p.m. - 2:15 p.m. ET. Cystatin C is a protein used as a biomar...

/Sepsis Treatment Market Driven by Growing Demand, Business Forecast, Covid 19 Review 2021 to 2026 | Biomerieux, Adrenomed AG, Cheetah Medical, BD Trending Sepsis Treatment Market Driven by Growing Demand, Business Forecast, Covid 19 Review 2021 to 2026 | Biomerieux, Adrenomed AG, Cheetah Medical, BD mohitFebruary 24, 2021 New research studies on the Sepsis Treatment Market give you a thorough understanding of the industry landscape and help with a better understanding of business and opport...

Share this article CHICAGO, Dec. 13, 2020 /PRNewswire/ --  A new study shows that a first-of-its-kind rapid test could identify which COVID-19 patients are responding to drug treatments and which patients are still deteriorating and need higher doses of medication. Findings on this method and on a second test that could predict COVID-19 severity were presented today at the virtual 2020 AACC Annual Scientific Meeting & Clinical Lab Expo. A Test That Shows If COVID-19 Treatment Is Working Studie...